| Drug
safety advice |
|
•
|
Tibolone
(Livial): increased risk of breast cancer recurrence |
|
•
|
Non-steroidal
anti-inflammatory drugs: cardiovascular risk |
| Yellow
Card scheme update |
|
•
|
Reporting
guidance |
|
Stop
Press
|
|
•
|
Toremifene
(Fareston): risk of QT prolongation |
|
•
|
Methylphenidate:
new guidance for use in treatment of ADHD |
|
•
|
Latest
safety information online |
|
•
|
Correction:
Temsirolimus—severe hypersensitivity reactions during infusion
|
| Other
information from the MHRA |
|
•
|
Patient
Information Leaflet of the month: Actonel-Once-a-Week |
|
•
|
Consultation:
measures to strengthen the medicines’ supply chain |
